Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/04/2026 | Q4 | $355.6M | -- | -- | $0.67 | -- |
| 11/05/2025 | Q3 | $345.4M | $363.9M | $0.65 | $0.60 | $0.05 |
| 08/27/2025 | Q2 | $362.2M | $378.7M | $0.42 | $0.52 | -$0.10 |
| 05/07/2025 | Q1 | $352.4M | $347.8M | $0.51 | $0.52 | -$0.01 |
| 02/05/2025 | Q4 | $316.5M | $309.3M | $0.08 | $0.45 | -$0.37 |
| 11/06/2024 | Q3 | $246.6M | $260.4M | $0.17 | $0.25 | -$0.08 |
| 08/28/2024 | Q2 | $260.5M | $273.2M | $0.02 | $0.33 | -$0.31 |
| 05/08/2024 | Q1 | $253.6M | $263.2M | $0.21 | $0.29 | -$0.08 |
| 02/07/2024 | Q4 | $240.9M | $249.9M | $0.03 | $0.28 | -$0.25 |
| 11/08/2023 | Q3 | $242M | $231.3M | -$0.20 | $0.23 | -$0.43 |
| 08/30/2023 | Q2 | -- | $255M | $0.28 | -- | -- |
| 05/03/2023 | Q1 | -- | $245.7M | $0.25 | -- | -- |
| 02/08/2023 | Q4 | -- | $244.6M | $0.18 | -- | -- |
| 11/09/2022 | Q3 | -- | $232.5M | $0.10 | -- | -- |
| 08/24/2022 | Q2 | -- | $255.3M | $0.18 | -- | -- |
| 05/04/2022 | Q1 | -- | $239.6M | $0.44 | -- | -- |
| 02/09/2022 | Q4 | -- | $232.7M | $0.43 | -- | -- |
| 11/02/2021 | Q3 | -- | $214.7M | $0.16 | -- | -- |
| 08/25/2021 | Q2 | -- | $220.3M | $0.42 | -- | -- |
| 05/06/2021 | Q1 | -- | $211.7M | $0.30 | -- | -- |
| 02/03/2021 | Q4 | -- | $206.1M | $0.32 | -- | -- |
| 11/04/2020 | Q3 | -- | $195.2M | $0.30 | -- | -- |
| 08/26/2020 | Q2 | -- | $185.9M | $0.14 | -- | -- |
| 05/07/2020 | Q1 | -- | $210.7M | $0.33 | -- | -- |
| 02/03/2020 | Q4 | -- | $214M | $0.29 | -- | -- |
| 11/04/2019 | Q3 | -- | $189.7M | $0.06 | -- | -- |
| 08/27/2019 | Q2 | -- | $203.9M | $0.22 | -- | -- |
| 05/06/2019 | Q1 | -- | $205.7M | $0.37 | -- | -- |
| 02/06/2019 | Q4 | -- | $218.2M | $0.36 | -- | -- |
| 11/06/2018 | Q3 | -- | $200.2M | $0.40 | -- | -- |
| 08/27/2018 | Q2 | -- | $211.8M | $0.55 | -- | -- |
| 05/07/2018 | Q1 | -- | $208.9M | $0.49 | -- | -- |
| 02/05/2018 | Q4 | -- | $205.9M | $0.17 | -- | -- |
| 11/06/2017 | Q3 | -- | $193.4M | $0.39 | -- | -- |
| 08/30/2017 | Q2 | -- | $194.8M | $0.38 | -- | -- |
| 05/08/2017 | Q1 | -- | $189.9M | $0.59 | -- | -- |
| 02/06/2017 | Q4 | -- | $191.6M | $0.34 | -- | -- |
| 11/10/2016 | Q3 | -- | $188M | $0.31 | -- | -- |
| 08/30/2016 | Q2 | -- | $189.2M | $0.38 | -- | -- |
| 05/09/2016 | Q1 | -- | $183.5M | $0.46 | -- | -- |
| 02/09/2016 | Q4 | -- | $191.8M | $0.75 | -- | -- |
Phibro Animal Health Corp. reported $363.9M worth of top line sales in its most recent quarter.
Phibro Animal Health Corp. announced earnings per share of $0.65 which represents a beat of analyst forecast a $0.60 per share.
Phibro Animal Health Corp. reported $119.3M that represents $2.92 per share over the last quarter.
Phibro Animal Health Corp.'s earnings are forecast to grow from $1.19 per share to $2.03 per share next year representing an increase of 130.88%.
Phibro Animal Health Corp.'s next earnings date is February 4, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.